Philip McFarlane


Associate Scientist, Li Ka Shing Knowledge Institute


Dr. Phil McFarlane is a clinical-investigator in the Division of Nephrology at St. Michael’s Hospital in Toronto, and an Assistant Professor at the University of Toronto. He is the Medical Director of Home Dialysis and the Chief Nephrologist in the Live Kidney Donor Program at St. Michael’s Hospital. He is a member of the Canadian Diabetes Association Clinical Practice Guidelines group, the Canadian Society of Nephrology guideline group, and the Canadian Hypertension Education Program. He has completed his PhD in health economics at the Institute for Medical Sciences (IMS) at the University of Toronto. His areas of research interest include health economics and outcomes research. He is currently the Provincial Medical Lead for dialysis access and home hemodialysis. He has published over 80 peer-reviewed manuscripts and three book chapters.

Recent Publications

  1. Nerenberg, KA, Zarnke, KB, Leung, AA, Dasgupta, K, Butalia, S, McBrien, K et al.. Hypertension Canada's 2018 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults and Children. Can J Cardiol. 2018;34 (5):506-525. doi: 10.1016/j.cjca.2018.02.022. PubMed PMID:29731013 .
  2. McFarlane, PA. Resistant Hypertension in Adults With Type 1 or 2 Diabetes: A Structured Diagnostic Approach. Can J Diabetes. 2018;42 (2):173-178. doi: 10.1016/j.jcjd.2018.01.001. PubMed PMID:29602405 .
  3. Goldenberg, RM, Berall, M, Chan, CTM, Cherney, DZI, Lovshin, JA, McFarlane, PA et al.. Managing the Course of Kidney Disease in Adults With Type 2 Diabetes: From the Old to the New. Can J Diabetes. 2018;42 (3):325-334. doi: 10.1016/j.jcjd.2017.06.008. PubMed PMID:28822777 .
  4. Leung, AA, Daskalopoulou, SS, Dasgupta, K, McBrien, K, Butalia, S, Zarnke, KB et al.. Hypertension Canada's 2017 Guidelines for Diagnosis, Risk Assessment, Prevention, and Treatment of Hypertension in Adults. Can J Cardiol. 2017;33 (5):557-576. doi: 10.1016/j.cjca.2017.03.005. PubMed PMID:28449828 .
  5. Soroka, S, Alam, A, Bevilacqua, M, Girard, LP, Komenda, P, Loertscher, R et al.. Assessing Risk of Disease Progression and Pharmacological Management of Autosomal Dominant Polycystic Kidney Disease: A Canadian Expert Consensus. Can J Kidney Health Dis. 2017;4 :2054358117695784. doi: 10.1177/2054358117695784. PubMed PMID:28321325 PubMed Central PMC5347414.
  6. Fitchett, DH, Goodman, SG, Leiter, LA, Lin, P, Welsh, R, Stone, J et al.. Secondary Prevention Beyond Hospital Discharge for Acute Coronary Syndrome: Evidence-Based Recommendations. Can J Cardiol. 2016;32 (7 Suppl):S15-34. doi: 10.1016/j.cjca.2016.03.002. PubMed PMID:27342696 .
  7. Leung, AA, Nerenberg, K, Daskalopoulou, SS, McBrien, K, Zarnke, KB, Dasgupta, K et al.. Hypertension Canada's 2016 Canadian Hypertension Education Program Guidelines for Blood Pressure Measurement, Diagnosis, Assessment of Risk, Prevention, and Treatment of Hypertension. Can J Cardiol. 2016;32 (5):569-88. doi: 10.1016/j.cjca.2016.02.066. PubMed PMID:27118291 .
  8. Davies, EW, Matza, LS, Worth, G, Feeny, DH, Kostelec, J, Soroka, S et al.. Health state utilities associated with major clinical events in the context of secondary hyperparathyroidism and chronic kidney disease requiring dialysis. Health Qual Life Outcomes. 2015;13 :90. doi: 10.1186/s12955-015-0266-9. PubMed PMID:26122041 PubMed Central PMC4487205.
  9. Alam, A, Dahl, NK, Lipschutz, JH, Rossetti, S, Smith, P, Sapir, D et al.. Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: A Biomarker of Disease Progression and Therapeutic Efficacy. Am. J. Kidney Dis. 2015;66 (4):564-76. doi: 10.1053/j.ajkd.2015.01.030. PubMed PMID:25960302 .
  10. Daskalopoulou, SS, Rabi, DM, Zarnke, KB, Dasgupta, K, Nerenberg, K, Cloutier, L et al.. The 2015 Canadian Hypertension Education Program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol. 2015;31 (5):549-68. doi: 10.1016/j.cjca.2015.02.016. PubMed PMID:25936483 .
Search PubMed

Affiliations & Other Activities

  • Clinical Investigator, St. Michael’s Hospital
  • Medical Director, Home Dialysis, St. Michael’s Hospital
  • Assistant Professor, Division of Nephrology, Dept. of Medicine, University of Toronto